| Unique ID issued by UMIN | UMIN000060222 |
|---|---|
| Receipt number | R000068884 |
| Scientific Title | Study to Confirm the Effects of Sea Buckthorn Juice Intake on Immune Activity and Physical Condition |
| Date of disclosure of the study information | 2025/12/31 |
| Last modified on | 2025/12/28 20:13:23 |
Study to Confirm the Effects of Sea Buckthorn Juice Intake on Immune Activity and Physical Condition
Study to Confirm the Effects of Sea Buckthorn Juice Intake on Immune Activity and Physical Condition
Study to Confirm the Effects of Sea Buckthorn Juice Intake on Immune Activity and Physical Condition
Study to Confirm the Effects of Sea Buckthorn Juice Intake on Immune Activity and Physical Condition
| Japan |
Healthy Adults
| Adult |
Others
NO
The objective is to investigate whether pDC activity in dendritic cells increases and to examine the frequency of cold symptoms during the intake period in 140 adult men and women who subjectively perceive themselves as susceptible to colds, by having them consume Sea Buckthorn juice or placebo juice for 12 weeks.
Safety,Efficacy
Health Status Questionnaire
pDC activity
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
YES
NO
Institution is not considered as adjustment factor.
YES
No need to know
2
Treatment
| Food |
Intake of Sea Buckthorn juice
Intake of placebo juice
| 20 | years-old | <= |
| 60 | years-old | >= |
Male and Female
(1) Healthy adult men and women aged 20 to 60 years
(2) Individuals who subjectively perceive themselves as prone to catching colds
(3) Individuals who can provide written informed consent to participate in the study
(1) Individuals currently receiving medication for any disease
(2) Individuals with serious diseases or psychiatric disorders affecting glucose metabolism, lipid metabolism, liver function, kidney function, heart, circulatory system, respiratory system, endocrine system, immune system, or nervous system. Also, individuals with a history of such conditions
(3) Individuals with a disease currently undergoing treatment, or those with a history of serious disease requiring medication
(4) Individuals participating in another clinical study at the start of this trial
(5) Individuals deemed unsuitable for trial participation by the Principal Investigator (or Study Director)
140
| 1st name | Ryuji |
| Middle name | |
| Last name | Takeda |
Kansai University of Welfare Sciences
Department of Nutritional Sciences for Welll-being, Faculty of Health Science for Welfare
582-0026
Asahigaoka 3-11-1, Kashiwara, Osaka
0729780088
rtakeda@tamateyama.ac.jp
| 1st name | Shigenori |
| Middle name | |
| Last name | Nibun |
EAS inc.
Clinical Trial Session
236-0028
Susaki-Cho1-10-2F, Kanazawa-ku, Yokohama city, Kanagawa
045-374-3392
info@eas-ct.jp
Sajii-berry Holdings inc.
Sajii-berry Holdings inc.
Profit organization
KOBUNA ORTHOPEDIC SURGERY
311-2, Gokan-machi, Maebashi, Gunma
027-261-7600
sagawa@mc-connect.co.jp
NO
| 2025 | Year | 12 | Month | 31 | Day |
Unpublished
Preinitiation
| 2025 | Year | 10 | Month | 20 | Day |
| 2026 | Year | 01 | Month | 03 | Day |
| 2026 | Year | 04 | Month | 30 | Day |
| 2025 | Year | 12 | Month | 28 | Day |
| 2025 | Year | 12 | Month | 28 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068884